Search company, investor...

Chiltern International

Founded Year



Acquired | Acquired



About Chiltern International

Chiltern is a leading global clinical CRO offering specialized services in oncology and a range of other therapeutic areas, together with global sourcing and FSP solutions. Chiltern's 2,100 people work in more than 40 countries and offer expertise, engagement and tailored, responsive solutions to meet the demands of biotech and pharmaceutical partners of all sizes.

Headquarters Location

171 Bath Road Slough

Berkshire, England, SL1 4AA,

United Kingdom

+44 (0)1753 512000

Missing: Chiltern International's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Chiltern International's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Chiltern International

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Chiltern International is included in 1 Expert Collection, including Diabetes.



1,903 items

Latest Chiltern International News

Early Phase Clinical Trial Outsourcing Market Financial Guide for 2027 by Leading Players- ICON plc., QuintilesIMS, PAREXEL International Corporation., Chiltern International Ltd., Sofpromed, Covance Inc.

Jun 21, 2021

Search jobs 21-Jun-2021 Early Phase Clinical Trial Outsourcing Market Financial Guide for 2027 by Leading Players- ICON plc., QuintilesIMS, PAREXEL International Corporation., Chiltern International Ltd., Sofpromed, Covance Inc. Clinical trials are generally conducted to collect data regarding safety and efficacy of new drugs and devices development. There are multiple stages of drug approval in clinical trial process before drug or device can be sold in the market. In general, drugs or devices must undergo several phases of clinical trial that include preclinical, clinical trials to get market approval. Impact of COVID-19 on the Healthcare Industry The COVID-19 pandemic has causedsevere impacts on the global economy at various levels and which can be seen onthe Healthcare industry as well. The thriving market of health care researchand development is expected to exhibit a steep decline in the sales during thelockdown period owing to the shutdown of the manufacturing units, acuteshortage in the supply of raw materials and absence of potential manpower. Itcan be deduced from the current situations brought about by the pandemic thatthe production, and supply chain activities have experienced minor hurdles.However, the market is projected to gradually recover post-COVID-19, which willpresent attractive opportunities for sales across various regions of the worldin the following years. Future Market Insights (FMI) adopteda multidisciplinary approach during the pandemic-era to focus on the growth anddevelopment of the EarlyPhase Clinical Trial Outsourcing Market . The study features insights on the current growth dynamics and themajor revenue reforms prevailing in the market as along with the key takeawaysover the forecast. The team of analysts at Future MarketInsights are focussing on research and market study to produce different EarlyPhase Clinical Trial Outsourcing Market forecasts and predictions at bothnational and international levels. They have considered several leads ofinformation pertaining to the industry like market figures and mergerestimations to assess and produce reliable and informative insights on the EarlyPhase Clinical Trial Outsourcing Market. To remain ‘ahead’ of your competitors, Ask aQuestion >> Key Players The writer will create content on thegeneral strategies of market players. And then will write the key players inthe market are: PRA Health Sciences,INC Research, ICON plc., QuintilesIMS,PAREXEL International Corporation., Chiltern International Ltd., Sofpromed,Covance Inc Segmentation The report provides insights on the important highlights and currenttrends prevailing in the market. This helps the readers to gain a deeperunderstanding and form an unbiased opinion on the market. Numeroussegmentations have been provided for this market based on: Based on the trial phase, the earlyphase clinical trial outsourcing market is segmented into the following: Phase 0 Regulatory Services Pharmaceutical Companies Fullin-depth analysis of the parent market The analysts at FMI are dedicated toprovide insights after extensive research and study. The study also includesestimations, projections and evaluation of the market dynamics. Importantchanges in market dynamics The report has beencreated after detailed and exhaustive studies by the analysts at FMI takingseveral factors into consideration like monetary, ecological, social,mechanical, and political status of a particular demography. They study the keydata to assess the revenue and production of manufacturers across variousregions. The report also covers an in-depth analysis ofthe key changes in market dynamics in the recent past and the near future. Segmentationdetails of the market Emerging segments and regional markets Queries Solved What is the size of the overall Early PhaseClinical Trial Outsourcing Market in the Healthcare Industry and its segments? What are the key segments andsub-segments in the market? What are the key drivers, restraints,opportunities, and challenges of the Early Phase Clinical Trial OutsourcingMarket in the Healthcare Industry, and how they are expected to impact themarket? What are the attractive investmentopportunities within the Early Phase Clinical Trial Outsourcing Market in theHealthcare Industry? What is the Early Phase Clinical TrialOutsourcing Market in the Healthcare Industry size at the regional andcountry-level? What are the key market playersfocusing on? What are the strategies for growthadopted by the key players in Early Phase Clinical Trial Outsourcing Market inthe Healthcare Industry? What are the recent trends in EarlyPhase Clinical Trial Outsourcing Market in the Healthcare Industry? (M&A,partnerships, new product developments, expansions)? What are the challenges to the EarlyPhase Clinical Trial Outsourcing Market in the growth of the HealthcareIndustry? What are the key market trendsimpacting the growth of the Early Phase Clinical Trial Outsourcing Market inthe Healthcare Industry? To receive extensive list of importantregions, ask for TOC here >> Table of Content MarketBackground    Reasons to Buythe report We provide authentic and detailed ananalysis on various market trends to enable businesses to make informed andbeneficial decisions to attain competitive edge over key players. Our analysts provide detailed marketsegmentation along with meaningful insights and extensive reports that othercompanies fail to include. The report includes accurate analysisof the market and the current developing trends affecting the growth. FMI speaks tostakeholders across the spectrum, including C-level executives, distributors,product manufacturers, industry experts. This ensures that the data collected is fromhighly reliable sources. Explore Wide-ranging Coverage of FMI’s HealthcareLandscape Transradial Closure Devices Market – According to Future Market Insights (FMI), the demand from hospitals,independent catheterization centers, and healthcare clinics will continuerising. Spurred by this, the global transradial closure devices market is setto grow by 6.5% CAGR during the forecast period from the year 2020 to 2030. In Vitro FertilizationBanking Services Market – The in vitro fertilization banking services market,despite undergoing a temporary period of lull due to COVID-19 outbreak, islikely to have an impressive growth trajectory between 2020 and 2030. Cryopreservationfor In-vitro Fertilization (IVF) Market – According to analysis by Future Market Insights (FMI), cryopreservationfor IVF market surpassed a valuation of US$ 339 million in 2019. Themarket is set to reflect an impressive 10.2% CAGR through 2030. About FMI        Future Market Insights (FMI) is a leading provider of marketintelligence and consulting services, serving clients in over 150countries. FMI  isheadquartered in Dubai, the global financial capital, and has delivery centersin the U.S. and India. FMI’s latest  marketresearch reports  and industry analysis help businesses navigatechallenges and make critical decisions with confidence and clarity amidstbreakneck competition. Our customized and syndicated market research reportsdeliver actionable insights that drive sustainable growth. A team of expert-ledanalysts at FMI continuously tracks emerging trends and events in a broad rangeof industries to ensure that our clients prepare for the evolving needs oftheir consumers. ContactUs

Chiltern International Frequently Asked Questions (FAQ)

  • When was Chiltern International founded?

    Chiltern International was founded in 1982.

  • Where is Chiltern International's headquarters?

    Chiltern International's headquarters is located at 171 Bath Road, Berkshire.

  • What is Chiltern International's latest funding round?

    Chiltern International's latest funding round is Acquired.

  • Who are the investors of Chiltern International?

    Investors of Chiltern International include LabCorp.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.